-
Contains�12�relevant, practice-oriented topics�including�analytic and clinical performance of major commercial SARS-CoV-2 PCR assays in the United States; isothermal assays for SARS-CoV-2 detection; rapid antigen assays for SARS-CoV-2; approaches to deployment of molecular testing for SARS-CoV-2 in resource-limited settings; and more.�
-
Provides in-depth�clinical reviews on�COVID-19�molecular�testing and�clinical�correlates,�offering�actionable insights for clinical practice.�
-
Presents the�latest information on this timely, focused topic�under the leadership of experienced editors in the field.�Authors synthesize and distill the latest research and practice guidelines to create�clinically significant,�topic-based reviews.�
Please Note: This is an On Demand product, delivery may take up to 11 working days after payment has been received.
Table of Contents
Analytic and Clinical Performance of Major Commercial Severe Acute Respiratory Syndrome Coronavirus 2 Molecular Assays in the United StatesThe Successes and Challenges of SARS-CoV-2 Molecular Testing in the United States
An Overview of SARS-CoV-2 Molecular Diagnostics in Europe
SARS-CoV-2 Molecular Diagnostics in China
Rapid Antigen Assays for SARS-CoV-2: Promise and Peril
Clinical Diagnostic Point-of-Care Molecular Assays for SARS-CoV-2
Cycle Threshold Values from Severe Acute Respiratory Syndrome Coronavirus-2 Reverse Transcription-Polymerase Chain Reaction Assays: Interpretation and Potential Use Cases
Performance of Non-nasopharyngeal Sample Types for Molecular Detection of SARS-CoV-2
Strategies for Scaling up SARS-CoV-2 Molecular Testing Capacity
Approaches to Deployment of Molecular Testing for SARS-CoV-2 in Resource-Limited Settings
Novel Assays for Molecular Detection of Severe Acute Respiratory Syndrome Coronavirus 2
